Rainmaker
Loading page...
Explore selected deals shaping the global legal market
Loading the featured deals...
Explore major deals shaping the global legal market — from high-value mergers to landmark transactions across industries.
Explore major deals shaping the global legal market — from high-value mergers to landmark transactions across industries.
Sorting
Filters
- Gibson Dunn represented Gyre Therapeutics, Inc. in its definitive agreement to acquire Cullgen Inc. in an all-stock transaction valued at approximately $300 million, announced on March 3, 2026. - Under the terms of the agreement, Cullgen will become a wholly owned subsidiary of Gyre, and the transaction is expected to close early in the second quarter of 2026, subject to customary closing conditions and necessary regulatory approvals in the United States. - The acquisition will combine Gyre’s commercial-stage fibrosis business with Cullgen’s targeted protein degradation and degrader-antibody conjugate platform, creating a fully integrated biopharmaceutical company with U.S.- and China-based capabilities across discovery, manufacturing, and commercialization.
Mar 03 2026
300M
M&A
- Kirkland & Ellis LLP represented the acquiring consortium led by Global Infrastructure Partners, a part of BlackRock, and the EQT Infrastructure VI fund, together with co-underwriters California Public Employees’ Retirement System and Qatar Investment Authority, in its definitive agreement to acquire AES for $15.00 per share in cash. The transaction values AES at a total equity value of $10.7 billion and an enterprise value of approximately $33.4 billion, including the assumption of existing debt. - The transaction was unanimously approved by AES’ board of directors and is expected to close in late 2026 or early 2027, subject to AES stockholder approval, the receipt of applicable federal, state and foreign regulatory approvals, and other customary closing conditions. - Through the acquisition, AES is expected to expand its leadership as a clean energy platform across the Americas. AES is the largest supplier of clean energy to corporations globally and has signed agreements for 11.8 GW of power supply to major technology firms.
Mar 02 2026
33.4B
- Sidley represented Precision NeuroMed Inc. in its strategic partnership with Brainlab SE under a Joint Development and Commercialization Agreement. This strategic partnership was entered into on 2026-02-27. - Under the agreement, the companies will collaborate to develop and commercialize a cloud-based, AI-enabled treatment planning platform for convection enhanced delivery to the brain, and Brainlab has also received an equity interest in Precision NeuroMed. - Precision NeuroMed is a clinical-stage biotechnology company advancing precision therapeutics for central nervous system diseases, and the platform is intended to support more precise and personalized drug delivery to brain tissue.
Feb 27 2026
17M
M&A
- Almanac acquired the target/assets from Alterra IOS in a private equity transaction on 2026-02-27. - Deal value was 500000000 Sector: Industrial Outdoor Storage. - On the acquirer side, Kirkland & Ellis advised, led by Pete Vaglio, Josh Morgan.
Feb 27 2026
500M
Private Equity
- Willkie Farr & Gallagher LLP represented Peoria Resources, LLC, a subsidiary of JAPEX (U.S.) Corp., in its approximately $1.26 billion acquisition of the entire operated oil and gas business of Verdad Resources Holdings LLC, completed on February 26, 2026. - Willkie also advised Peoria on a reserve-based debt facility financing in connection with the acquisition. - The acquired portfolio comprises approximately 101,000 net acres across Colorado and Wyoming in the Denver-Julesburg Basin, focused on horizontal Niobrara and Codell formation development.
Feb 26 2026
1.3B
M&A
- Sidley represented The Brink’s Company in its acquisition of NCR Atleos Corporation in a cash and stock transaction valued at approximately $6.6 billion, announced on February 26, 2026. - Under the terms of the deal, Brink’s will acquire each outstanding share of NCR Atleos for $30.00 in cash and 0.1574 shares of Brink’s common stock, and the transaction is expected to close in the first quarter of 2027, subject to customary closing conditions, including regulatory and shareholder approvals. - The transaction combines two financial technology infrastructure providers, bringing together Brink’s cash management and route-based infrastructure with NCR Atleos’ ATM management, ATM network, and ATM-as-a-Service outsourcing capabilities.
Feb 26 2026
6.6B
M&A
- Kirkland & Ellis LLP represented Braemont Capital, as special counsel, in the $500 million non-control growth equity investment in VFN Holdings, Inc. (Vero Networks), announced on February 23, 2026 and led by Braemont Capital, Hamilton Lane, and Delta-v Capital. - The investment is intended to support Vero’s next phase of growth, including the expansion of its fiber-to-the-premise and wholesale fiber networks, as well as continued strategic M&A across new and existing U.S. markets. - Vero Networks is a fiber infrastructure business and broadband internet provider based in Boulder, Colorado, serving retail consumers, schools, government entities, enterprises, carriers, and hyperscale and cloud providers across the United States.
Feb 25 2026
500M
Private Equity
- Gibson Dunn represented Arcosa, Inc. in its definitive agreement to sell Arcosa Marine Products, Inc. to Wynnchurch Capital, L.P. for $450 million, announced on February 25, 2026. - The transaction represents a corporate carve-out of Arcosa’s marine products business and will establish Arcosa Marine as an independent standalone platform under Wynnchurch ownership, subject to customary closing conditions and applicable regulatory approvals. - Headquartered in Covington, Louisiana, Arcosa Marine manufactures hopper barges, tank barges, fiberglass covers, and marine components for the inland waterway transportation market and operates six manufacturing facilities across the inland waterway system.
Feb 25 2026
450M
M&A
- This is the unwind of SABIC's 2007 GE Plastics acquisition, at roughly 4 cents on the dollar. The ETP assets Mutares is taking (Lexan, Cycoloy, Valox, Cycolac brands; the Mt. Vernon, Burkville, Bergen op Zoom sites) were the crown jewels of GE Plastics, which SABIC acquired in 2007 for $11.6 billion ACS C&EN. They're now changing hands at $450M EV on roughly $2.5 billion in annual sales ACS C&EN — a revenue/EV ratio that tells you everything about how brutal the polycarbonate/ABS cycle has become. - The economics are even softer than the headline EV suggests. Both SABIC deals are structured with little or no upfront cost for the buyers, with SABIC instead receiving a share of future earnings Chemistry World via a four-year earn-out tied to free cash flow (and a share of any onward sale by Mutares). In substance this is closer to a carve-out with deferred/contingent consideration than a clean $450M cash sale — which fits Mutares' special-situations model and explains why many industry players and traditional buyers looked at these assets and passed Chemistry World. - It's one half of a paired $950M SABIC exit from Western petrochemicals, and a genuine strategic pivot for Mutares. Same-day, SABIC sold its European Petrochemicals business to fellow Munich firm Aequita for $500M — part of SABIC's broader portfolio optimization reflecting Saudi Vision 2030 capital reallocation toward higher-margin Asian/domestic growth. For Mutares, historically an auto/industrial turnaround shop, this is the largest transaction in Mutares' history Mutares and launches a brand-new ""Chemicals & Materials"" segment, anchored by ETP alongside the existing Venator Ultramarine Blue Pigments platform — worth flagging given Willkie's deep Frankfurt/Munich PE bench led the deal (Abrar, Linde, Dendl) with Houston (Giggs) and Chicago (Chang) covering the US chemicals footprint.
- Kirkland & Ellis advised an investor group (including General Catalyst and Trian Fund Management) on a definitive agreement to acquire Janus Henderson Group plc (NYSE: JHG) for $7.4 billion. - Under the agreement, shareholders not already owned or controlled by Trian will receive $49.00 per share in cash; the deal was announced December 22, 2025 and is expected to close in mid-2026, subject to customary conditions (including regulatory approvals, client consents, and shareholder approval). - The matter was handled by a cross-practice Kirkland team spanning corporate, capital markets, debt finance, tax, and investment funds.
Dec 22 2025
7.4B
Private Equity
- Paul, Weiss is advising a Warburg Pincus- and Permira-led investor group on its $8.4 billion acquisition of Clearwater Analytics. - The transaction will take Clearwater Analytics private under the consortium’s ownership (as announced in the deal materials). - The matter is being handled by a cross-practice Paul, Weiss team supporting the sponsors across corporate/M&A and related workstreams.
Dec 21 2025
8.4B
Private Equity
- Japan Petroleum Exploration Co., Ltd. acquired the target/assets from Verdad Resources Intermediate Holdings LLC in a acquisition on 2025-12-19. - Deal value was 1300000000 Sector: Energy. - On the acquirer side, Willkie advised, led by Brad Honeycutt, Tan Lu.
Dec 19 2025
1.3B
M&A
- BioMarin Pharmaceutical Inc. acquired the target/assets from Amicus Therapeutics in a Acquisition on 2025-12-19. - Deal value was 4800000000 Sector: Biotechnology; Location: San Rafael. - On the acquirer side, Jones Day advised, led by Jonn Beeson, Andy Levine, Michael Tollini, Addison Pierce.
Dec 19 2025
4.8B
M&A
- Gibson Dunn advised J.P. Morgan Asset Management as co-lead investor in the Series L financing round of Databricks. - The matter was announced by the firm on December 19, 2025. - The engagement was handled by a cross-practice Gibson Dunn team, spanning corporate and tax support.
Dec 19 2025
4B
Finance
Private Equity
Jan 12 2026
450M
Private Equity
